Lantheus (LNTH)
(Delayed Data from NSDQ)
$112.50 USD
+0.54 (0.48%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $112.50 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$112.50 USD
+0.54 (0.48%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $112.50 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
BRKR's Canopy Biosciences Partners With Enable Medicine
by Zacks Equity Research
BRKR's Canopy Biosciences collaborates with Enable Medicine to bring advanced spatial analysis pipelines to the Canopy CellScape System for high-plex spatial biology.
2 Top Ranked Stocks with Strong Momentum
by Ethan Feller
Using Zacks Premium Screens, I have identified three stocks with improving earnings expectations and strong momentum
Palo Alto Networks and RH have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Palo Alto Networks and RH are part of the Zacks Bull and Bear of the Day article.
Illumina (ILMN) Partners With Henry Ford Health for NGS Test
by Zacks Equity Research
Illumina (ILMN) collaborates with Henry Ford Health to conduct a series of studies that is likely to focus on the genetic drivers of cardiovascular disease.
Lantheus Holdings (LNTH) Stock Moves 0.96%: What You Should Know
by Zacks Equity Research
Lantheus Holdings (LNTH) closed the most recent trading day at $86.35, moving +0.96% from the previous trading session.
3 Medical Product Stocks With Strong Potential to Gain in 2023
by Indrajit Bandyopadhyay
Here we discuss three medical instruments stocks, LNTH, RMTI and VMD, which are witnessing solid momentum in 2023. These stocks have the potential to continue their uptrend going forward.
Investors Heavily Search Lantheus Holdings, Inc. (LNTH): Here is What You Need to Know
by Zacks Equity Research
Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Henry Schein (HSIC) Acquires Majority Stake in Biotech Dental
by Zacks Equity Research
Henry Schein (HSIC) announces that the completion of the Biotech Dental partnership brings forth the company's several important solutions to customers.
Quest Diagnostics (DGX) Advances Access to Transplant Services
by Zacks Equity Research
Quest Diagnostics' (DGX) upgrade to advanced diagnostics and support services is likely to feature personalized patient access to service centers and mobile phlebotomists.
Lantheus Holdings (LNTH) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Lantheus Holdings (LNTH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment
by Zacks Equity Research
Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.
Zacks.com featured highlights Lantheus, Perion Network, Alliance Resource Partners and Sea
by Zacks Equity Research
Lantheus, Perion Network, Alliance Resource Partners and Sea have been highlighted in this Screen of The Week article.
Zacks.com featured highlights Bellerophon Therapeutics, Crawford, Riley Exploration Permian, Harrow Health and Lantheus
by Zacks Equity Research
Bellerophon Therapeutics, Crawford, Riley Exploration Permian, Harrow Health and Lantheus have been highlighted in this Screen of The Week article.
Here's What Makes UnitedHealth Group (UNH) a Lucrative Bet Now
by Zacks Equity Research
UnitedHealth Group (UNH) is well-poised for growth on the back of a growing customer base within its government businesses, efficient telehealth services and solid cash-generating abilities.
Is Lantheus (LNTH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Lantheus Holdings (LNTH) and Novo Nordisk (NVO) have performed compared to their sector so far this year.
4 Top-Performing Liquid Stocks to Scoop for Strong Returns
by Zacks Equity Research
Here are four top-ranked liquid stocks, Lantheus Holdings (LNTH), Alliance Resource Partners (ARLP), Perion Network (PERI) and Sea Limited (SE), which investors can add to their portfolio for solid gains.
5 Stocks With Recent Price Strength Amid March Rally
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are BLPH, CRD.B, REPX, HROW and LNTH.
Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day.
3 Medical Stocks Creating Wealth Despite Macro Challenges
by Indrajit Bandyopadhyay
Here we discuss three stocks - LNTH, OMER and HYPR - that have been creating wealth for their investors in 2023 even though several competitors faltered amid macro challenges. Will the trend continue?
Here's Why You Should Retain HCA Healthcare (HCA) Stock Now
by Zacks Equity Research
HCA Healthcare (HCA) remains well-poised for growth on the back of improved revenues, a well-diversified healthcare portfolio and sufficient cash-generating abilities.
Recent Price Trend in Lantheus Holdings (LNTH) is Your Friend, Here's Why
by Zacks Equity Research
Lantheus Holdings (LNTH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Zacks.com featured highlights include Lantheus, Perion Network, Meta Platforms and Sea
by Zacks Equity Research
Lantheus, Perion Network, Meta Platforms and Sea are part of the Zacks Screen of the Week article.
Walgreens (WBA) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Walgreens' (WBA) strategic executions on the United States and the international front is likely to have contributed to the Q2 2023 top line.
4 Top-Ranked Liquid Stocks for Strong Returns in 2023
by Vaishali Doshi
Here are four top-ranked liquid stocks, Lantheus Holdings (LNTH), Meta Platforms (META), Perion Network (PERI) and Sea Limited (SE), which investors can add to their portfolio for strong gains.
Does Lantheus Holdings (LNTH) Have the Potential to Rally 32.44% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Lantheus Holdings (LNTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.